Literature DB >> 11992862

Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.

David J Browning1.   

Abstract

PURPOSE: To report hydroxychloroquine and chloroquine retinopathy and consider screening for drug toxicity.
DESIGN: Retrospective observational case series.
METHODS: Review of clinical records, visual fields, fundus photographs, and fluorescein angiography of six patients from a retina referral practice.
RESULTS: All cases arose because of failure by physicians to avoid dosing above published safe levels. Five cases developed despite accepted ophthalmologic patterns of screening for toxicity. All cases developed parafoveal retinal pigment epithelial atrophic changes and paracentral scotomas to threshold visual field testing.
CONCLUSIONS: New cases of hydroxychloroquine and chloroquine toxicity continue to develop in a screening environment. Increased ophthalmologic attention to dosing, awareness of location and nature of early visual field defects, and traditional attention to presence or absence of maculopathy can reduce the incidence of this avoidable condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992862     DOI: 10.1016/s0002-9394(02)01392-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

1.  Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Jasmine W S Ngai; Wai-Man Chan; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2006-06-28       Impact factor: 2.379

2.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

3.  A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.

Authors:  Javad Heravian; Massoud Saghafi; Naser Shoeibi; Samira Hassanzadeh; Mohammad Taghi Shakeri; Maria Sharepoor
Journal:  Int Ophthalmol       Date:  2011-07-12       Impact factor: 2.031

4.  [Ophthalmologic screening history and vision-targeted health status of patients suffering from chloroquine maculopathy].

Authors:  R Bergholz; K Rüther; H Tillack; A M Joussen; J Schroeter
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

Review 5.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

6.  Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.

Authors:  Lucia Tanga; Marco Centofanti; Francesco Oddone; Mariacristina Parravano; Vincenzo Parisi; Lucia Ziccardi; Barbara Kroegler; Roberto Perricone; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-21       Impact factor: 3.117

7.  Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.

Authors:  Xiao-Yu Zheng; Lin-Jie Li; Wei Li; Pei-Fang Jiang; Hong-Qiang Shen; Ying-Hu Chen; Xi Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-03       Impact factor: 3.117

8.  Toxicity of selected cationic drugs in retinoblastomal cultures and in cocultures of retinoblastomal and retinal pigment epithelial cell lines.

Authors:  Hanna Mäenpää; Tarja Toimela; Marika Mannerström; Pirjo Saransaari; Hanna Tähti
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

9.  Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.

Authors:  R V Jivrajka; M A Genead; J J McAnany; C C Chow; W F Mieler
Journal:  Eye (Lond)       Date:  2013-06-14       Impact factor: 3.775

10.  Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography.

Authors:  Ulrich Kellner; Simone Kellner; Silke Weinitz
Journal:  Doc Ophthalmol       Date:  2007-12-16       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.